Spots Global Cancer Trial Database for b lymphoblastic lymphoma
Every month we try and update this database with for b lymphoblastic lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia | NCT02877303 | B Acute Lymphob... B Lymphoblastic... | Blinatumomab Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Inotuzumab Ozog... Laboratory Biom... Mercaptopurine Methotrexate Ofatumumab Prednisone Rituximab Vincristine Sul... | 14 Years - | M.D. Anderson Cancer Center | |
CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+ | NCT06355739 | B Lymphocytic L... B Lymphoblastic... | CAR T cell inje... | 3 Years - 18 Years | Institute of Hematology & Blood Diseases Hospital, China | |
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia | NCT03914625 | B Acute Lymphob... B Lymphoblastic... Down Syndrome | Asparaginase Er... Blinatumomab Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Leucovorin Calc... Mercaptopurine Mercaptopurine ... Methotrexate Pegaspargase Prednisolone Prednisone Radiation Thera... Radiation Thera... Thioguanine Vincristine Sul... | 365 Days - 31 Years | National Cancer Institute (NCI) | |
Blinatumomab, Inotuzumab Ozogamicin, and Combination Chemotherapy as Frontline Therapy in Treating Patients With B Acute Lymphoblastic Leukemia | NCT02877303 | B Acute Lymphob... B Lymphoblastic... | Blinatumomab Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Inotuzumab Ozog... Laboratory Biom... Mercaptopurine Methotrexate Ofatumumab Prednisone Rituximab Vincristine Sul... | 14 Years - | M.D. Anderson Cancer Center | |
Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma | NCT05303792 | B Acute Lymphob... B Lymphoblastic... | Cyclophosphamid... Vincristine Dexamethasone Inotuzumab Ozog... Methotrexate Cytarabine Methylprednisol... Rituximab Prednisone Mercaptopurine Doxorubicin | 50 Years - | Alliance for Clinical Trials in Oncology | |
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia | NCT03914625 | B Acute Lymphob... B Lymphoblastic... Down Syndrome | Asparaginase Er... Blinatumomab Cyclophosphamid... Cytarabine Dexamethasone Doxorubicin Hyd... Leucovorin Calc... Mercaptopurine Mercaptopurine ... Methotrexate Pegaspargase Prednisolone Prednisone Radiation Thera... Radiation Thera... Thioguanine Vincristine Sul... | 365 Days - 31 Years | National Cancer Institute (NCI) | |
Testing the Combination of Inotuzumab Ozogamicin and Lower Dose Chemotherapy Compared to Usual Chemotherapy for Adults With B-Cell Acute Lymphoblastic Leukemia or B-Cell Lymphoblastic Lymphoma | NCT05303792 | B Acute Lymphob... B Lymphoblastic... | Cyclophosphamid... Vincristine Dexamethasone Inotuzumab Ozog... Methotrexate Cytarabine Methylprednisol... Rituximab Prednisone Mercaptopurine Doxorubicin | 50 Years - | Alliance for Clinical Trials in Oncology | |
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy | NCT03959085 | B Acute Lymphob... B Lymphoblastic... Central Nervous... Mixed Phenotype... Testicular Leuk... | Biospecimen Col... Bone Marrow Asp... Bone Marrow Bio... Bone Scan Calaspargase Pe... Computed Tomogr... Cyclophosphamid... Cytarabine Daunorubicin Hy... Dexamethasone Doxorubicin Hyd... Inotuzumab Ozog... Leucovorin Calc... Magnetic Resona... Mercaptopurine Methotrexate Pegaspargase Positron Emissi... Prednisolone Questionnaire A... Radiation Thera... Radiation Thera... Thioguanine Vincristine Sul... | 1 Year - 25 Years | Children's Oncology Group | |
CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+ | NCT06355739 | B Lymphocytic L... B Lymphoblastic... | CAR T cell inje... | 3 Years - 18 Years | Institute of Hematology & Blood Diseases Hospital, China | |
CD19-targeted CAR T Cell Autotransfusion for the Treatment of Recurrent/Refractory B-cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma in Children With CD19+ | NCT06355739 | B Lymphocytic L... B Lymphoblastic... | CAR T cell inje... | 3 Years - 18 Years | Institute of Hematology & Blood Diseases Hospital, China |